Novartis takes option on NASH drug from Conatus
Swiss pharma takes option on FXR agonist emricasan.
X
Novartis takes option on NASH drug from Conatus
https://pharmaphorum.com/news/novartis-takes-option-nash/
Swiss pharma takes option on FXR agonist emricasan.
